4//SEC Filing
GOOD JENNIFER L 4
Accession 0001104659-24-101365
CIK 0001649904other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:30 PM ET
Size
16.3 KB
Accession
0001104659-24-101365
Insider Transaction Report
Form 4
GOOD JENNIFER L
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-17$18.99/sh+7,501$142,444→ 34,751 total - Exercise/Conversion
Common Stock
2024-09-17$22.93/sh+15,000$343,950→ 18,000 total - Exercise/Conversion
Common Stock
2024-09-17$21.37/sh+9,250$197,673→ 27,250 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-17−15,000→ 0 totalExercise: $22.93Exp: 2029-06-18→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-09-17−7,501→ 0 totalExercise: $18.99Exp: 2031-06-08→ Common Stock (7,501 underlying) - Sale
Common Stock
2024-09-17$52.40/sh−31,751$1,663,803→ 3,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-17−9,250→ 0 totalExercise: $21.37Exp: 2030-06-16→ Common Stock (9,250 underlying)
Footnotes (3)
- [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 22, 2024.
- [F2]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $52.00 to $53.00. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001229245
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:30 PM ET
- Size
- 16.3 KB